HUP9802314A3 - Use of pure 3r-3'r stereoisomer of zeaxanthin for preparation of pharmaceuticals or foodstoffs for treating macular degeneration in humans - Google Patents

Use of pure 3r-3'r stereoisomer of zeaxanthin for preparation of pharmaceuticals or foodstoffs for treating macular degeneration in humans

Info

Publication number
HUP9802314A3
HUP9802314A3 HU9802314A HUP9802314A HUP9802314A3 HU P9802314 A3 HUP9802314 A3 HU P9802314A3 HU 9802314 A HU9802314 A HU 9802314A HU P9802314 A HUP9802314 A HU P9802314A HU P9802314 A3 HUP9802314 A3 HU P9802314A3
Authority
HU
Hungary
Prior art keywords
foodstoffs
zeaxanthin
stereoisomer
pharmaceuticals
humans
Prior art date
Application number
HU9802314A
Other languages
Hungarian (hu)
Original Assignee
Applied Food Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by Applied Food Biotech Inc filed Critical Applied Food Biotech Inc
Publication of HUP9802314A2 publication Critical patent/HUP9802314A2/en
Publication of HUP9802314A3 publication Critical patent/HUP9802314A3/en
Publication of HU223208B1 publication Critical patent/HU223208B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9802314A 1995-10-31 1996-10-30 Use of pure 3r-3'r stereoisomer of zeaxanthin for preparation of pharmaceuticals or foodstoffs for treating macular degeneration in humans HU223208B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
PCT/US1996/017563 WO1997016175A1 (en) 1995-10-31 1996-10-30 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans

Publications (3)

Publication Number Publication Date
HUP9802314A2 HUP9802314A2 (en) 1999-04-28
HUP9802314A3 true HUP9802314A3 (en) 1999-05-28
HU223208B1 HU223208B1 (en) 2004-03-29

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802314A HU223208B1 (en) 1995-10-31 1996-10-30 Use of pure 3r-3'r stereoisomer of zeaxanthin for preparation of pharmaceuticals or foodstoffs for treating macular degeneration in humans

Country Status (14)

Country Link
JP (1) JPH10512594A (en)
KR (1) KR100570251B1 (en)
CN (1) CN1104235C (en)
AR (1) AR004245A1 (en)
AU (1) AU710634B2 (en)
BR (1) BR9611488A (en)
CZ (1) CZ297575B6 (en)
FI (1) FI980947A (en)
HU (1) HU223208B1 (en)
NO (1) NO981698L (en)
PL (1) PL185465B1 (en)
RU (1) RU2197958C2 (en)
WO (1) WO1997016175A1 (en)
ZA (1) ZA969139B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) 2005-01-21 2005-03-02 Promar As Compositions
AU2006213635B2 (en) * 2005-02-11 2010-06-17 Kalamazoo Holdings, Inc. A Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
DK0534955T3 (en) * 1989-08-30 1997-10-13 Applied Food Biotech Inc Process for preparing a zeaxanthin-containing composition using a microorganism of the species Flavobacterium multivorum.
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
HUP9802314A2 (en) 1999-04-28
PL185465B1 (en) 2003-05-30
KR100570251B1 (en) 2006-06-21
AU710634B2 (en) 1999-09-23
CZ130998A3 (en) 1998-07-15
FI980947A0 (en) 1996-10-30
PL326558A1 (en) 1998-09-28
HU223208B1 (en) 2004-03-29
MX9605248A (en) 1998-06-30
CN1104235C (en) 2003-04-02
CN1201388A (en) 1998-12-09
RU2197958C2 (en) 2003-02-10
AU7050196A (en) 1997-05-08
ZA969139B (en) 1997-09-25
AR004245A1 (en) 1998-11-04
NO981698D0 (en) 1998-04-16
FI980947A (en) 1998-04-29
KR19990067180A (en) 1999-08-16
CZ297575B6 (en) 2007-02-07
JPH10512594A (en) 1998-12-02
BR9611488A (en) 1999-01-19
WO1997016175A1 (en) 1997-05-09
NO981698L (en) 1998-06-08

Similar Documents

Publication Publication Date Title
IL117793A0 (en) Method for the treatment of macular degeneration
ZA941773B (en) Therapeutic uses of bactericidal/permeability increasing protein products
HUP9800725A3 (en) 4-benzoyl-pyrozol derivatives, process for their preparation and their use as herbicides
AU1926295A (en) Skin tanning compositions and methods for their preparation and use
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
AU4104896A (en) Stable lycopene concentrates and process for their preparation
AU6522396A (en) Composition for cleaning or treating human or animal hair
IL123611A0 (en) Novel amino acid derivatives their preparation and use
IL114059A0 (en) Phenethanolamine derivatives pharmaceutical compositions containing them process for their preparation and their use
IL124768A0 (en) Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
CZ63895A3 (en) 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use
CZ92295A3 (en) Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof
IL108343A0 (en) 9H-imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
AU5526898A (en) Isomeric pharmaceutical formulation containing dfmo for the treatment of cancer
HUP9802314A3 (en) Use of pure 3r-3'r stereoisomer of zeaxanthin for preparation of pharmaceuticals or foodstoffs for treating macular degeneration in humans
HUT68007A (en) Pharmaceutical compositions for preventing and treating retinal diseases and process for preparing them
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and methods of use thereof
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
AU4489196A (en) Novel medical use of heme products
AUPN499895A0 (en) Hair treatment composition
IL130831A (en) Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20040216

MM4A Lapse of definitive patent protection due to non-payment of fees